Lung Cancer Podcasts Lung Cancer RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The role of the pathologist in the field of lung cancer
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, describes the increasing c... Author: VJOncology Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts

Breakthroughs in lung cancer from ASCO 2018: positive and negative
In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Ross Camidge, MD, PhD, of the University of Colorado, Denver, CO, gives his highlights from... Author: VJOncology Added: 08/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2018 Category: Cancer & Oncology Source Type: podcasts

Off-label medication use in lung cancer
With the increased use of next-generation sequencing (NGS) to identify mutations in patient's own cancer cells, the off-label usage of non-approved drugs is on the rise. In this interview, Federico Ca... Author: VJOncology Added: 08/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2018 Category: Cancer & Oncology Source Type: podcasts

JAMA Internal Medicine : Evaluating Shared Decision Making for Lung Cancer Screening
Interview with Daniel Scott. Reuland, MD MPH, author of Evaluating Shared Decision Making for Lung Cancer Screening, and Bruno Heleno, MD, PhD, author of Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 13, 2018 Category: General Medicine Source Type: podcasts

CCGA: plasma cfDNA lung cancer screening
Cell-free (cf)DNA analysis is frequently used in lung cancer to identify therapeutic targets, but there has also been recent interest in using this technology to create a minimally invasive cancer scr... Author: VJOncology Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Assessment and diagnostic workup for NSCLC in 2018
The assessment and diagnostic workup of newly diagnosed patients with advanced non-small cell lung cancer (NSCLC) is evolving, as discussed here by Nathan Pennell, MD, PhD, of the Cleveland Clinic, Cl... Author: VJOncology Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Assessment and diagnostic workup for NSCLC in 2018
The assessment and diagnostic workup of newly diagnosed patients with advanced non-small cell lung cancer (NSCLC) is evolving, as discussed here by Nathan Pennell, MD, PhD, of the Cleveland Clinic, Cl... Author: VJHemOnc Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Tepotinib in METex14 skipping alteration NSCLC
Enriqueta Felip, MD, PhD, of Vall dHebron University Hospital, Barcelona, Spain, discusses the VISION trial (NCT02864992) of tepotinib for non-small cell lung cancer (NSCLC) patients with MET exon 14... Author: VJOncology Added: 08/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2018 Category: Cancer & Oncology Source Type: podcasts

The Basics of a Lung Cancer Workup [720p]
Dr. Gerard Silvestri, Medical University of South Carolina, describes the steps necessary to work up a lung cancer diagnosis, from initial scan to choice of treatment. Author: cancergrace Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

Economic impact of NGS for NSCLC diagnostics
The use of sequential single-gene testing to detect genomic alterations in metastatic non-small cell lung cancer (NSCLC) can be costly, particularly with new mutations to test for being added as our k... Author: VJOncology Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE-189: chemo plus pembrolizumab for NSCLC
The KEYNOTE-189 ( NCT02578680) trial investigated the effects of adding pembrolizumab to cisplatin and pemetrexed in patients with non-small cell lung cancer (NSCLC). Here, Marina Garassino, MD, of th... Author: VJOncology Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

ATLANTIC: durvalumab in the fight against NSCLC
The ATLANTIC trial (NCT02087423) is currently underway to determine the effects of durvalumab on patients with advanced non-small cell lung cancer (NSCLC). Speaking from the American Society of Oncolo... Author: VJOncology Added: 07/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

Are There Significant Genetic Risks for Lung Cancer_ [720p]
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the genetic risk (or lack thereof) for lung cancer. Author: cancergrace Added: 07/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 31, 2018 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Risk Factors [720p]
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses smoking, asbestos, radon and other risk factors for lung cancer. Author: cancergrace Added: 07/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 30, 2018 Category: Cancer & Oncology Source Type: podcasts

he practice-changing outcomes from Keynote 189
Benjamin Philip Levy, MD, talks about the data from Keynote 189, specifically, how chemotherapy should be combined with immunotherapy in the treatment of 1st line non-small cell lung cancer (NSCLC)<br /> Author: obr Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2018 Category: Cancer & Oncology Source Type: podcasts